Gastroenterology

Uzm. Dr. Ayça Gökçen Değirmenci Saltürk

Doctor and researcher Medicana Kadıköy İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicana.com.tr.

  • Gastroskopi, kolonoskopi (polipektomi – polip çıkarılması)
  • Endoskopik mukozasal diseksiyon (EMR)
  • Endoskopik submukozal rezeksiyon (ESD)
  • Perkütan Endoskopik Gastrotomi (PEG)
  • Balon buji dilatasyonu, stent yerleştirme
  • Endoskopik Retrograd Kolanjiopankreatografi (ERCP) – kolanjioskop
  • Tanısal ve girişimsel endoskopik ultrasound (EUS)
  • İnflamatuvar barsak hastalıkları (Crohn hastalığı – ülseratif kolit)
  • Özofagus hastalıkları
  • Mide hastalıkları
  • İnce bağırsak hastalıkları
  • Karaciğer hastalıkları
  • Pankreas hastalıkları
  • Çölyak hastalığı
  • Manometri – PH Metri

CV

Education and experience

From source

Experience

  • 2025-HalenMedicana Kadıköy Hastanesimedicana.com.tr
  • 2023-2025Yeni Yüzyıl Üniversitesi Özel Gaziosmanpaşa Hastanesi, Gastroenteroloji Uzmanımedicana.com.tr
  • 2014-2023Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Gastroenteroloji Uzmanımedicana.com.tr
  • 2008-2014Haydarpaşa Numune Hastanesi, Yan Dal Asistanlığımedicana.com.tr
  • 2006-2008Tuzla Devlet Hastanesi, İç Hastalıkları Uzmanımedicana.com.tr
  • 2001-2006Göztepe Eğitim ve Araştırma Hastanesi, İç Hastalıkları Asistanlığımedicana.com.tr

Education

  • 2000Cerrahpaşa Tıp Fakültesimedicana.com.tr
  • 1994-2000İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi (Lisans)medicana.com.tr
  • 2001-2006Göztepe Eğitim ve Araştırma Hastanesi (İç Hastalıkları Asistanlığı)medicana.com.tr
  • 2008-2014Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (Gastroenteroloji Asistanlığı)medicana.com.tr
  • 2018Academic Medical Center, Department of Gastrointestinal Endoscopy, University of Amsterdammedicana.com.tr
  • 2018Academic Medical Center, Department of Gastrointestinal Endoscopy, University of Amsterdam. Observer. June 15–August 13medicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyGastroenterologymedicana.com.trFrom source
  • InstitutionMedicana Kadıköymedicana.com.trFrom source
  • Publications23 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:24https://www.medicana.com.tr/hekim-detay/24892/ayca-gokcen-degirmenci-salturkmedicana.com.tr

Scientific work

Publications

23 publications

  1. Changes in the clinical characteristics of chronic hepatitis B patients at the initiation of treatment over a 15-year period. Bahadir Ö, Degirmenci Salturk AG, Bahadir M. Hepatol Forum. 3(1): 11–15. 2022

    Source: medicana.com.tr profile page

  2. Adali G, Gokcen P, Fatih Guzelbulut F, Degirmenci Salturk AG, Agaoglu NB, Unal B, Doganay L, Ozdil K. Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection? Hepatol Forum. 2(3): 91–96. 2021

    Source: medicana.com.tr profile page

  3. Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy. Guzelbulut F, Gökçen P, Can G, Adalı G, Değirmenci Saltürk AG, Bahadır Ö, Özdil K, Doğanay HL. J Viral Hepat. 28:826–836. 2021

    Source: medicana.com.tr profile page

  4. Comparison of the efficacy of entecavir and tenofovir in reducing hepatocellular carcinoma risk in chronic hepatitis B patients: A real-life study in Turkey. Güzelbulut F, Gökçen P, Can G, Adalı G, Değirmenci Saltürk AG, Aslan E, Özdil K, Doğanay L. Turk J Gastroenterol. 32(4): 412–421. 2021

    Source: medicana.com.tr profile page

  5. Risk of hepatocellular carcinoma development in chronic hepatitis C patients who achieved a sustained virological response with interferon-based treatments. Bahadır Ö, Saltürk A, Kıyak M, Şahin H, Kanatsız E, Ceran N, Erol S, Güzelbulut F. 2021

    Source: medicana.com.tr profile page

  6. Influence of sustained virological response on APRI in chronic hepatitis C: Is APRI a marker of only the stage of fibrosis? Bahadır Ö, Özer S, Değirmenci Saltürk AG, Şahin H, Kıyak M, Kanatsız E, Saltürk C, Güzelbulut F. 2020

    Source: medicana.com.tr profile page

  7. The correlation between tenascin-C expression and formation of intestinal stricture. Erdem E, Kochan K, Paker N, Gokden Y, Degirmenci AS, Kocak F, Gonen C. North Clin Istanb. 1(3):127-131. 2014

    Source: medicana.com.tr profile page

  8. Glutaraldehyde-induced colitis: three case reports. Kurdaş OO, Sezikli M, Cetinkaya ZA, Güzelbulut F, Yaşar B, Coşgun S, Değirmenci AS. Indian J Gastroenterol. 28(6):221-223. 2009

    Source: medicana.com.tr profile page

  9. Diagnostıc performance of MR enterography for assessment of terminal ileum in Crohn’s Disease. Gonen C, Salturk A, Gokden Y, Koçhan K. UEG Week 2015

    Source: medicana.com.tr profile page

  10. PegIFNs are not satisfactory in genotype D chronic HBV infection. Övünç AO, Guzelbulut F, Gökden Y, Senates E, Çetinkaya ZA, Degirmenci A, Yasar B. Hepatology. 50:523A–524A. 2009

    Source: medicana.com.tr profile page

View all 23 publications